 | Up a level |
Wang, Shuu-Jiun and Roxas, Artemio A and Saravia, Bibiana and Kim, Byung-Kun and Chowdhury, Debashish and Riachi, Naji and Tai, Mei-Ling Sharon and Tanprawate, Surat and Ngoc, Tai Tran and Zhao, Yi Jing and Mikol, Daniel D and Pandhi, Shaloo and Wen, Shihua and Mondal, Subhayan and Tenenbaum, Nadia and Hours-Zesiger, Peggy (2021) Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study. Cephalalgia, 41 (13). pp. 1285-1297. ISSN 0333-1024, DOI https://doi.org/10.1177/03331024211024160.
